Tranexplus is a Dermaqual topical professional pigmentation-care essence containing tranexamic acid, high- and low-molecular-weight hyaluronic acid, niacinamide, ascorbyl glucoside and glutathione in five 5 ml vials.

Tranexamic acid has clinical literature in melasma across several routes, but outcomes and risks are route- and formulation-specific and do not prove this exact multi-ingredient product.

Catalogue visual: Tranexplus (Renewal Essence) from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.

What it is

Dermaqual positions Tranexplus for melasma, post-inflammatory hyperpigmentation, ultraviolet-related uneven tone and dullness and lists topical application. Tranexamic acid may reduce pigmentation signalling associated with the plasminogen pathway, while niacinamide and a vitamin C derivative provide additional cosmetic brightening rationale and HA supports hydration. Diagnosis and ultraviolet protection remain central because pigment disorders are chronic, heterogeneous and prone to recurrence. The public page does not state active concentrations or provide a product-specific controlled trial.

Market position and alternatives

Tranexplus competes with topical combination pigment products and clinician-directed melasma regimens.

Potential advantages

• The formula combines pigment-focused ingredients with high- and low-molecular-weight HA for hydration support.
• Topical tranexamic acid has a clinical evidence base in melasma, although studies are heterogeneous.
• The five 5 ml vials facilitate lot, seal and expiry checks in clinic inventory.
• The official topical route avoids conflating the product with oral tranexamic acid and its systemic risk assessment.

Limitations and buying considerations

• No independent controlled trial of Tranexplus itself was found.
• The public manufacturer page does not state tranexamic acid or supporting-active concentrations.
• Evidence differs across oral, injected and topical tranexamic acid and should not be pooled into a product guarantee.
• Melasma commonly recurs and requires diagnosis, daily photoprotection and a maintenance plan.

Quality and authenticity checklist

• Confirm tranexamic acid, two HA molecular-weight categories, niacinamide, ascorbyl glucoside and glutathione on the current pack.
• Match the five sterile 5 ml vials to Dermaqual's live listing.
• Inspect carton and vial seals, batch and expiry and request current storage information.
• Verify topical-use directions and reject any unverified oral or injection protocol attached by a reseller.

Price and availability in Pakistan

The current Tranexplus price in Pakistan is available by quotation from NEES Medical; no verified numeric PKR price is published in the live catalogue. A quote should state the original five-by-5 ml presentation, current expiry and delivery conditions.

Sources and further reading

• Dermaqual — Tranexplus
• Tranexamic Acid for Melasma: Meta-analysis of Randomized Trials
• Efficacy of Oral, Topical and Intradermal Tranexamic Acid in Melasma

View the Tranexplus (Renewal Essence) catalogue page or request current pricing and availability.